Document Detail

Safety and Efficacy of Thrombolysis with Intravenous Alteplase in Older Stroke Patients.
MedLine Citation:
PMID:  23338796     Owner:  NLM     Status:  Publisher    
Stroke is a common cause of death and persisting disability worldwide, and thrombolysis with intravenous alteplase is the only approved treatment for acute ischaemic stroke. Older age is the most important non-modifiable risk factor for stroke, and demographic changes are also resulting in an increasingly ageing population. However, clinical trial evidence for the use of intravenous alteplase is limited for the older age group where stroke incidence is highest. In this article, the current evidence regarding the safety and efficacy of intravenous thrombolytic therapy in stroke patients aged ≥80 years is critically analysed and the gap in current knowledge highlighted. In summary, intravenous thrombolysis in stroke patients aged ≥80 years seems to be associated with less favourable clinical outcomes and higher mortality than in younger patients, which is consistent with the natural course in untreated patients. The risk of symptomatic intracranial haemorrhage does not appear to be significantly higher in the elderly group, suggesting that intracranial bleeding complications are unlikely to outweigh the potential benefit in this age group. Overall, withholding thrombolytic treatment in ischaemic stroke on the basis of advanced age alone is no longer justifiable.
Hakan Sarikaya
Related Documents :
24723776 - First record of the male of the widespread calliscelioelegans (perkins) (hymenoptera, p...
25047636 - Correction: cognitive ability in late adolescence and disability pension in middle age:...
22037296 - Masticatory performance in older subjects with varying degrees of tooth loss.
24132776 - Comparative reproductive output of androphilic and gynephilic males in samoa.
21069536 - Exposure to urban stressors and free testosterone plasma values.
6523736 - Analysis of human crystalline lens curvature as a function of accommodative state and age.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-22
Journal Detail:
Title:  Drugs & aging     Volume:  -     ISSN:  1170-229X     ISO Abbreviation:  Drugs Aging     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9102074     Medline TA:  Drugs Aging     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Neurology, University Hospital of Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adjuvant Pharmacotherapy in the Management of Elderly Patients with Pancreatic Cancer.
Next Document:  Inhibition of repair-related DNA polymerases by vitamin Ks, their related quinone derivatives and as...